Stress & Social Cognition in BPD (Part 2)
- Conditions
- Borderline Personality Disorder
- Interventions
- Drug: PlaceboDrug: FludrocortisoneBehavioral: Trier Social Stress Test (TSST)Behavioral: Placebo Trier Social Stress Test (P-TSST)
- Registration Number
- NCT05310253
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).
- Detailed Description
The investigators will examine whether MR stimulation enhances prosocial behavior in BPD patients under additional psychosocial stress. Participants will be randomly assigned to receive either fludrocortisone as an MR stimulant or placebo. Afterwards, participants will either undergo the stress or placebo condition of the Trier Social Stress Test ((P-)TSST). Subsequently, cognitive and emotional empathy, as well as sharing and punishment behavior will be measured.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 240
Not provided
- acute depressive episode,
- acute or lifetime psychotic symptoms
- acute substance abuse
- physical illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Fludrocortisone & TSST - BPD patients Trier Social Stress Test (TSST) intake of 0.4mg fludrocortisone (orally) before stress Fludrocortisone & TSST - Healthy controls Trier Social Stress Test (TSST) intake of 0.4mg fludrocortisone (orally) before stress Placebo pills & TSST - BPD patients Placebo intake of placebo pill before stress Placebo pills & TSST - BPD patients Trier Social Stress Test (TSST) intake of placebo pill before stress Placebo pills & TSST - Healthy controls Placebo intake of placebo pill before stress Placebo pills & TSST - Healthy controls Trier Social Stress Test (TSST) intake of placebo pill before stress Fludrocortisone & Placebo-TSST- BPD patients Fludrocortisone intake of 0.4mg fludrocortisone (orally) before "no stress" Fludrocortisone & Placebo-TSST- BPD patients Placebo Trier Social Stress Test (P-TSST) intake of 0.4mg fludrocortisone (orally) before "no stress" Fludrocortisone & Placebo-TSST - Healthy controls Fludrocortisone intake of 0.4mg fludrocortisone (orally) before "no stress" Fludrocortisone & Placebo-TSST - Healthy controls Placebo Trier Social Stress Test (P-TSST) intake of 0.4mg fludrocortisone (orally) before "no stress" Placebo pills & Placebo-TSST - BPD patients Placebo Trier Social Stress Test (P-TSST) intake of placebo pill before "no stress" Placebo pills & Placebo-TSST - Healthy controls Placebo intake of placebo pill before "no stress" Placebo pills & Placebo-TSST - Healthy controls Placebo Trier Social Stress Test (P-TSST) intake of placebo pill before "no stress" Fludrocortisone & TSST - BPD patients Fludrocortisone intake of 0.4mg fludrocortisone (orally) before stress Fludrocortisone & TSST - Healthy controls Fludrocortisone intake of 0.4mg fludrocortisone (orally) before stress
- Primary Outcome Measures
Name Time Method Empathy: Multifaceted Empathy Test 15 minutes after (P-)TSST correct answers (mental state of the subject in the photos), rating of own emotional reaction
- Secondary Outcome Measures
Name Time Method Sharing behavior 10 minutes after (P-)TSST amount of monetary units (max 100) shared with co-player
Punishment behavior 10 minutes after (P-)TSST number of rejected offers from co-player
Trial Locations
- Locations (1)
Charite University
🇩🇪Berlin, Germany